NeuroBo Pharmaceuticals, Inc. Appoints D. Gordon Strickland to its Board of Directors
/PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced the appointment of D. Gordon Strickland...
Stay updated with breaking news from Applied Technical Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced the appointment of D. Gordon Strickland...
/PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced the appointment of D. Gordon Strickland...
BOSTON, Jan. 28, 2022 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company, today announced the appointment of D. Gordon Strickland to its Board of Directors,... | January 28, 2022
/PRNewswire/ -- Market to Grow and reach $11.16 Billion in 2025 according to the "Non-Destructive Testing (NDT) and Inspection Global Market Report 2021:...
/PRNewswire/ -- Market to Grow and reach $11.16 Billion in 2025 according to the "Non-Destructive Testing (NDT) and Inspection Global Market Report 2021:...